Chemistry and Biology (Volume 52) (The Alkaloids, Volume 52)
0124695523
9780124695528
Description:
Alkaloids are a major group of natural products derived from a variety of organisms, which are widely used as medicinal and biological agents. This Series is world-renowned as the leading compilation of current reviews of this vast field. Internationally acclaimed for more than 40 years, this Series, founded by the late Professor R.H.F. Manske, continues to provide outstanding coverage of the rapidly expanding field of the chemotaxonomy, structure elucidation, synthesis, biosynthesis, and biology of all classes of alkaloids from higher and lower plants, marine organisms, or various terrestrial animals.
Each volume provides, through its distinguished authors, up-to-date and detailed coverage of particular classes or sources of alkaloids. Over the years, this Series has become the standard in natural product chemistry to which all other book series aspire. The Alkaloids: Chemistry and Biology endures as an essential reference for all natural product chemists and biologists who have an interest in alkaloids, their diversity, and their unique biological profile.
Best prices to buy, sell, or rent ISBN 9780124695528
Frequently Asked Questions about Chemistry and Biology (Volume 52) (The Alkaloids, Volume 52)
The price for the book starts from $52.99 on Amazon and is available from 9 sellers at the moment.
If you’re interested in selling back the Chemistry and Biology (Volume 52) (The Alkaloids, Volume 52) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Chemistry and Biology (Volume 52) (The Alkaloids, Volume 52) book, the best buyback offer comes from and is $ for the book in good condition.
The Chemistry and Biology (Volume 52) (The Alkaloids, Volume 52) book is in very low demand now as the rank for the book is 11,723,378 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.